The uptake and utility of genetic testing and genetic counseling for hypertrophic cardiomyopathy-A systematic review and meta-analysis

被引:10
|
作者
Cirino, Allison L. [1 ,2 ]
Harris, Stephanie L. [3 ]
Murad, Andrea M. [4 ]
Hansen, Brittany [5 ]
Malinowski, Jennifer [6 ]
Natoli, Jaime L. [7 ]
Kelly, Melissa A. [8 ]
Christian, Susan [9 ]
机构
[1] Brigham & Womens Hosp, Cardiovasc Div, 75 Francis St, Boston, MA 02115 USA
[2] MGH Inst Hlth Profess, 36 First Ave, Boston, MA 02129 USA
[3] Massachusetts Gen Hosp, Div Cardiol, Cardiovasc Genet Program, Boston, MA USA
[4] Univ Michigan, Div Med Genet, Dept Internal Med, Ann Arbor, MI USA
[5] Cleveland Clin, Genom Med Inst, Ctr Personalized Genet Healthcare, Cleveland, OH USA
[6] Write Inscite South Salem, New York, NY USA
[7] Kaiser Permanente, Southern Calif Permanente Med Grp, Pasadena, CA USA
[8] Genom Med Inst, Geisinger, Danville, PA USA
[9] Univ Alberta, Dept Med Genet, Edmonton, AB, Canada
关键词
cascade testing; genetic counseling; genetic testing; hypertrophic cardiomyopathy; predictive genetic testing; systematic review; utility; QUALITY-OF-LIFE; FOLLOW-UP; MUTATION CARRIERS; RELATIVES; CHILDREN; RISK; IMPACT; POPULATION; PENETRANCE; KNOWLEDGE;
D O I
10.1002/jgc4.1604
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Genetic testing and genetic counseling are routinely indicated for patients with hypertrophic cardiomyopathy (HCM); however, the uptake and utility of these services is not entirely understood. This systematic review and meta-analysis summarizes the uptake and utility of genetic counseling and genetic testing for patients with HCM and their at-risk family members, as well as the impact of genetic counseling/testing on patient-reported outcomes (PROs). A systematic search was performed through March 12, 2021. Meta-analyses were performed whenever possible; other findings were qualitatively summarized. Forty-eight studies met inclusion criteria (47 observational, 1 randomized). Uptake of genetic testing in probands was 57% (95% confidence interval [CI]: 40, 73). Uptake of cascade screening for at-risk relatives were as follows: 61% for cascade genetic testing (95% CI: 45, 75), 58% for cardiac screening (e.g. echocardiography) (95% CI: 40, 73), and 69% for either/both approaches (95% CI: 43, 87). In addition, relatives of probands with a positive genetic test result were significantly more likely to undergo cascade screening compared to relatives of probands with a negative result (odds ratio = 3.17, 95% CI: 2.12, 4.76). Overall, uptake of genetic counseling in both probands and relatives ranged from 37% to 84%. Multiple studies found little difference in PROs between individuals receiving positive versus negative genetic test results; however, other studies found that individuals with positive genetic test results experienced worse psychological outcomes. Genetic testing may also inform life choices, particularly decisions related to reproduction and insurance. Genetic counseling was associated with high satisfaction, increased perceived personal control and empowerment, and decreased anxiety. Approximately half to three-quarters of patients with HCM and their relatives undergo genetic testing or cascade screening. PROs after genetic testing varied and genetic counseling was associated with high satisfaction and improved PROs.
引用
收藏
页码:1290 / 1305
页数:16
相关论文
共 50 条
  • [1] Diagnostic validity and clinical utility of genetic testing for hypertrophic cardiomyopathy: a systematic review and meta-analysis
    Christian, Susan
    Cirino, Allison
    Hansen, Brittany
    Harris, Stephanie
    Murad, Andrea M.
    Natoli, Jaime L.
    Malinowski, Jennifer
    Kelly, Melissa A.
    OPEN HEART, 2022, 9 (01):
  • [2] Diagnostic Validity of Genetic Testing for Hypertrophic Cardiomyopathy - A Systematic Review and Meta-Analysis
    Kelly, Melissa A.
    Cirino, Allison
    Hansen, Brittany P.
    Harris, Stephanie
    Murad, Andrea M.
    Natoli, Jaime
    Malinowski, Jennifer
    Christian, Susan
    CIRCULATION, 2021, 144
  • [3] Meta-Analysis of Penetrance and Systematic Review on Transition to Disease in Genetic Hypertrophic Cardiomyopathy
    Topriceanu, Constantin-Cristian
    Pereira, Alexandre C.
    Moon, James C.
    Captur, Gabriella
    Ho, Carolyn Y.
    CIRCULATION, 2024, 149 (02) : 107 - 123
  • [4] Genetic Testing and Counseling for Hypertrophic Cardiomyopathy
    Cirino, Allison L.
    Seidman, Christine E.
    Ho, Carolyn Y.
    CARDIOLOGY CLINICS, 2019, 37 (01) : 35 - +
  • [5] Meta-Analysis of Penetrance in Genetic Hypertrophic Cardiomyopathy
    Topriceanu, Constantin-Cristian
    Pereira, Alexandre C.
    Moon, James C.
    Captur, Gabriella
    Ho, Carolyn Y.
    CIRCULATION, 2023, 148
  • [6] Uptake of predictieve genetic testing in hypertrophic cardiomyopathy
    Christiaans, I.
    Van Langen, I. M.
    Dijksman, L. M.
    Birnie, E.
    Bonsel, G. J.
    Wilde, A. A. M.
    EUROPEAN HEART JOURNAL, 2006, 27 : 951 - 951
  • [7] Genetic Counseling and Testing for Hypertrophic Cardiomyopathy: the Pediatric Perspective
    Demo, Erin M.
    Skrzynia, Cecile
    Baxter, Samantha
    JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2009, 2 (04) : 500 - 507
  • [8] Genetic Counseling and Testing for Hypertrophic Cardiomyopathy: the Pediatric Perspective
    Erin M. Demo
    Cécile Skrzynia
    Samantha Baxter
    Journal of Cardiovascular Translational Research, 2009, 2 : 500 - 507
  • [9] Genetic Counseling and Testing for Hypertrophic Cardiomyopathy: An Adult Perspective
    Skrzynia, Cecile
    Demo, Erin M.
    Baxter, Samantha M.
    JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2009, 2 (04) : 493 - 499
  • [10] Genetic Counseling and Testing for Hypertrophic Cardiomyopathy: An Adult Perspective
    Cécile Skrzynia
    Erin M. Demo
    Samantha M. Baxter
    Journal of Cardiovascular Translational Research, 2009, 2 : 493 - 499